Checkpoint Therapeutics, Inc.

CIK 1651407 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Checkpoint Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2025SCHEDULE 13G/A0000935836-25-000512
Jun 9, 202515-12G0001104659-25-057621
Jun 4, 2025EFFECT9999999995-25-001822
Jun 4, 2025EFFECT9999999995-25-001826
Jun 4, 2025EFFECT9999999995-25-001821
Jun 4, 2025EFFECT9999999995-25-001823
Jun 4, 2025EFFECT9999999995-25-001819
Jun 4, 2025EFFECT9999999995-25-001820
Jun 3, 202540001415889-25-015470
Jun 3, 2025SCHEDULE 13D/A0001104659-25-056072
May 30, 202540001104659-25-054695
May 30, 202540001104659-25-054684
May 30, 202540001104659-25-054687
May 30, 2025POS AM0001104659-25-054632
May 30, 2025S-8 POS0001104659-25-054646
May 30, 2025POS AM0001104659-25-054638
May 30, 202540001104659-25-054688
May 30, 2025S-8 POS0001104659-25-054645
May 30, 2025POS AM0001104659-25-054637
May 30, 202540001104659-25-054690
May 30, 20258-K0001104659-25-054628
May 30, 2025POS AM0001104659-25-054635
May 30, 202525-NSE0001354457-25-000474
May 30, 202540001104659-25-054698
May 30, 2025POS AM0001104659-25-054634